People-First Solutions
We are motivated to improve patient experiences. Our technology offers patients a proven alternative to pills and injections and they benefit from improved delivery of actives for faster clinical effect and symptom relief.
Collaborative Partnerships
We understand your business goals and work collaboratively with you to address common pain points in order to deliver sustainable solutions and improved experiences for your customers.
Purpose-Driven Mission
We’re on a mission to make medications easier to take, more efficacious, and with increased tolerability and fewer side effects. When the burden of taking medication is eliminated, patient adherence increases.
Our mission is to improve lives by redefining how medicines are delivered and experienced.
We are a drug delivery and development company with a propietary formulation and delivery platform. Based in the U.S., we are a vertically-integrated oral thin film manufacturer, and our marquis technology is CUREfilm®, an oral dissolvable film. Our innovative oral thin film formulation makes medications easier to take, more efficacious, and with fewer tolerability and side effects.
Ranked internationally as a prominent player in the oral thin films market*, we partner with companies to improve investigational and marketed drugs and dietary supplements.
*Source: Market Research Future Reports, 2018
Latest News
CURE Pharmaceutical Expands Board with Two Women Directors
August 07, 2019
Oxnard, Calif. – August 7, 2019 – CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and...READ MORE
Latest News
CURE Pharmaceutical Secures Patent on High Loading of Active Ingredient in Oral Thin Films
July 24, 2019
OXNARD, Calif. – July 24, 2019 - CURE Pharmaceutical (OTC:CURR), an innovative drug delivery and...READ MORE
Latest News
CURE Pharmaceutical Secures Patent on Oral Thin Films With Bi-Phasic Release of Natural Ingredients
July 16, 2019
OXNARD, Calif. – July 16, 2019 - CURE Pharmaceutical (OTC:CURR), an innovative drug delivery and...READ MORE
Read Our Blog
PharmaVoice Woman of the Week Podcast features Jessica Rousset, Chief Operating Officer, CURE
June 04, 2019
This podcast and transcript are republished with permission from PharmaVoice. --------------...READ MORE
Read Our Blog
FAQs: CURE Pharmaceutical to Acquire Chemistry Holdings Inc.,
April 03, 2019
On Monday, April 1, we announced our plans to acquire Chemistry Holdings, a formulation technology company...READ MORE
Read Our Blog
Hemp’s Future looks Bright: The 2018 Farm Bill
December 20, 2018
The 2018 Farm Bill, which was passed by Congress and signed by President Donald Trump today, is a...READ MORE